Viatris makes progress on Ozempic patent challenge By: MarketWatch October 04, 2023 at 17:05 PM EDT Board agrees to review patent covering certain strengths of blockbuster diabetes drug Read More >> Related Stocks: Novo Nordisk A/S ADR Viatris Inc